All Relations between cb2 and cannabinoids

Publication Sentence Publish Date Extraction Date Species
Paola Nieri, Enrica Martinotti, Lara Testai, Cinzia Martinelli, Maria Cristina Bresch. Effects of cannabinoids on non-adrenergic non-cholinergic-mediated relaxation in guinea-pig trachea. European journal of pharmacology. vol 475. issue 1-3. 2004-05-03. PMID:12954367. the effect of win 55,212-2 was not modified by the cannabinoid cb1 and cb2 receptor-selective antagonists, n-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1h-pyrazole-3-carboxamide hydrochloride (sr141716a; 10(-5) m) and n-(1s)-endo-1,3,3-trimethyl bicyclo [2.2.1] heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide (sr 144528; 10(-5) m), respectively. 2004-05-03 2023-08-12 Not clear
Paola Nieri, Enrica Martinotti, Lara Testai, Cinzia Martinelli, Maria Cristina Bresch. Effects of cannabinoids on non-adrenergic non-cholinergic-mediated relaxation in guinea-pig trachea. European journal of pharmacology. vol 475. issue 1-3. 2004-05-03. PMID:12954367. in conclusion, our results suggest that (a) cannabinoid cb1 and cb2 receptor stimulation does not alter the inhibitory nanc transmission in guinea-pig trachea, and (b) win 55,212-2 potentiates the no-mediated component of the nanc relaxant response to electrical stimulation through a cannabinoid receptor-independent mechanism. 2004-05-03 2023-08-12 Not clear
Allyn Franklin, Nephi Stell. Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. European journal of pharmacology. vol 474. issue 2-3. 2004-04-23. PMID:12921861. arachidonylcyclopropylamide increases microglial cell migration through cannabinoid cb2 and abnormal-cannabidiol-sensitive receptors. 2004-04-23 2023-08-12 mouse
Clara Di Filippo, Francesco Rossi, Settimio Rossi, Michele D'Amic. Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN. Journal of leukocyte biology. vol 75. issue 3. 2004-04-23. PMID:14657208. cannabinoid cb2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and pmn. 2004-04-23 2023-08-12 mouse
Clara Di Filippo, Francesco Rossi, Settimio Rossi, Michele D'Amic. Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN. Journal of leukocyte biology. vol 75. issue 3. 2004-04-23. PMID:14657208. in this study, we have assessed the activation of the cannabinoid cb2 receptor (cb2-r) in a model of mouse myocardial ischemia/reperfusion (i/r). 2004-04-23 2023-08-12 mouse
Erica J Carrier, Christopher S Kearn, Andrew J Barkmeier, Nicole M Breese, Wenqi Yang, Kasem Nithipatikom, Sandra L Pfister, William B Campbell, Cecilia J Hillar. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Molecular pharmacology. vol 65. issue 4. 2004-04-21. PMID:15044630. cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a cb2 receptor-dependent mechanism. 2004-04-21 2023-08-12 rat
Susanna M Saario, Juha R Savinainen, Jarmo T Laitinen, Tomi Järvinen, Riku Niem. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochemical pharmacology. vol 67. issue 7. 2004-04-13. PMID:15013854. 2-arachidonoylglycerol (2-ag) is an endogenous cannabinoid that binds to cb1 and cb2 cannabinoid receptors, inducing cannabimimetic effects. 2004-04-13 2023-08-12 rat
Celine Gongora, Stacey Hose, Terrence P O'Brien, Debasish Sinh. Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940. Immunology letters. vol 91. issue 1. 2004-03-30. PMID:14757364. many effects of cannabinoids are mediated by two g-protein coupled receptors, designated cb1 and cb2. 2004-03-30 2023-08-12 Not clear
Andis Klegeris, Christopher J Bissonnette, Patrick L McGee. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. British journal of pharmacology. vol 139. issue 4. 2004-03-24. PMID:12813001. 1 two cannabinoid receptors, cb1 and cb2, have been identified. 2004-03-24 2023-08-12 human
Andrew J Irving, Mark G Rae, Angela A Coutt. Cannabinoids on the brain. TheScientificWorldJournal. vol 2. 2004-03-23. PMID:12805989. cannabinoids act primarily via two types of receptor, cb1 and cb2, with cb1 receptors mediating most of the central actions of cannabinoids. 2004-03-23 2023-08-12 Not clear
Thomas W Klein, Cathy Newton, Kellie Larsen, Joe Chou, Izabella Perkins, Lily Lu, Liang Nong, Herman Friedma. Cannabinoid receptors and T helper cells. Journal of neuroimmunology. vol 147. issue 1-2. 2004-03-15. PMID:14741435. receptor antagonists for cb1 (sr141716a, sr1) and cb2 (sr144528, sr2) were also injected to analyze the involvement of cannabinoid receptors. 2004-03-15 2023-08-12 mouse
Andrea G Hohmann, Jesse N Farthing, Alexander M Zvonok, Alexandros Makriyanni. Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin. The Journal of pharmacology and experimental therapeutics. vol 308. issue 2. 2004-03-11. PMID:14610224. selective activation of cannabinoid cb2 receptors suppresses hyperalgesia evoked by intradermal capsaicin. 2004-03-11 2023-08-12 Not clear
Giovanna Zolese, Michal Wozniak, Paolo Mariani, Letizia Saturni, Enrico Bertoli, Annarina Ambrosin. Different modulation of phospholipase A2 activity by saturated and monounsaturated N-acylethanolamines. Journal of lipid research. vol 44. issue 4. 2004-03-02. PMID:12562826. the binding with cannabinoid receptors cb1 and cb2 was demonstrated for some naes, such as anandamide. 2004-03-02 2023-08-12 Not clear
Asha K Nadipuram, Mathangi Krishnamurthy, Antonio M Ferreira, Wei Li, Bob M Moor. Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors. Bioorganic & medicinal chemistry. vol 11. issue 14. 2004-02-27. PMID:12818675. synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the cb1 and cb2 receptors. 2004-02-27 2023-08-12 Not clear
Asha K Nadipuram, Mathangi Krishnamurthy, Antonio M Ferreira, Wei Li, Bob M Moor. Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors. Bioorganic & medicinal chemistry. vol 11. issue 14. 2004-02-27. PMID:12818675. a series of c3 cyclic side-chain analogues of classical cannabinoids were synthesized to probe the ligand binding pocket of the cb1 and cb2 receptors. 2004-02-27 2023-08-12 Not clear
Xiang-Qun Xie, Jian-Zhong Chen, Eric M Billing. 3D structural model of the G-protein-coupled cannabinoid CB2 receptor. Proteins. vol 53. issue 2. 2004-02-26. PMID:14517981. 3d structural model of the g-protein-coupled cannabinoid cb2 receptor. 2004-02-26 2023-08-12 cattle
Xiang-Qun Xie, Jian-Zhong Chen, Eric M Billing. 3D structural model of the G-protein-coupled cannabinoid CB2 receptor. Proteins. vol 53. issue 2. 2004-02-26. PMID:14517981. the cannabinoid (cb) receptor subtype cb2 is of particular interest due to its involvement in signal transduction in the immune system and its increased characterization by mutational and other studies. 2004-02-26 2023-08-12 cattle
Alison J Drysdale, Bettina Plat. Cannabinoids: mechanisms and therapeutic applications in the CNS. Current medicinal chemistry. vol 10. issue 24. 2004-02-02. PMID:14529462. to date, two distinct cannabinoid receptors (cb1 and cb2) have been discovered, but evidence for further receptor types has been brought forward. 2004-02-02 2023-08-12 Not clear
Claudio Castellano, Clelia Rossi-Arnaud, Vincenzo Cestari, Marco Costanz. Cannabinoids and memory: animal studies. Current drug targets. CNS and neurological disorders. vol 2. issue 6. 2004-01-30. PMID:14683467. two subtypes of cannabinoid receptors have been identified to date: the central cb1 subtype and the peripheral cb2 subtype. 2004-01-30 2023-08-12 mouse
Mathangi Krishnamurthy, Antonio M Ferreira, Bob M Moor. Synthesis and testing of novel phenyl substituted side-chain analogues of classical cannabinoids. Bioorganic & medicinal chemistry letters. vol 13. issue 20. 2004-01-12. PMID:14505654. a series of novel phenyl substituted side-chain analogues of classical cannabinoids were synthesized and their cb1 and cb2 binding affinities were evaluated relative to delta(8)-thc and compound 2. 2004-01-12 2023-08-12 Not clear